Cytokeratin (CK) Profile in Thymomas

CK 10 Is a Marker for Cortical Thymomas and CK 20 a Marker for Medullary Thymomas
  • J. P. Enoksson
  • M. Albertsson
  • A. Cervin
  • K. Friström
  • L. Johansson


Thymomas are epithelial tumors that have a strong correlation to autoimmune disease. A classification that correlates with prognosis has been proposed. We classified 79 thymoma specimens and identified the CK immunophenotypes of these tumors.


Perivascular Space Thymic Carcinoma Perivascular Cell Medullary Cell Thymic Epithelial Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rosai J, Levine GD. Tumors of the thymus. In: Atlas of tumor pathology, 2nd series, fascicle 13. Armed Forces Institute of Pathology, 1976. Washington.Google Scholar
  2. 2.
    Pescarmona E, Rendina EA, Venuta F, Ricci C, Ruco LP, Baroni CD. The prognostic implication of thymoma histologic subtyping: A study of 80 consecutive cases. Am J Clin Pathol. 1990:93(2): 190–195.PubMedGoogle Scholar
  3. 3.
    Lewis JE, Wick MR, Scheithauer BW et al: Thymoma: A clinicopathological review. Cancer. 1987; 60:2727–2743.PubMedCrossRefGoogle Scholar
  4. 4.
    Kornstein MJ. Pathology of the thymus and mediastinum. Vol 33 in the series Major Problems in Pathology. WB Saunders, Philadelphia 1995.Google Scholar
  5. 5.
    Kendall MD: The morphology of perivascular spaces in the thymus. Thymus. 1989; 13:157–164.PubMedGoogle Scholar
  6. 6.
    Müller-Hermelink HK, Marino M, Palestro G, Schumacher U, Kirchner T. Immunohistological evidence of cortical and medullary differentiation in thymoma. Virchows Arch A Pathol Anat Histopathol. 1985;408:143–161.PubMedCrossRefGoogle Scholar
  7. 7.
    Marino M, Müller-Hermelink HK: Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of the thymus. Virchows Arch A Pathol Anat Histopathol. 1985; 407:119–49.PubMedCrossRefGoogle Scholar
  8. 8.
    Kirchner T, Müller-Hermelink HK: New approaches to the diagnosis of thymic epithelial tumors. Prog Surg Pathol. 1989; 10:167–189.Google Scholar
  9. 9.
    Quintanilla-Martinez L, Wilkins EW Jr, Choi N, Efird J, Hug E, Harris NL: Thymoma. Histologic subclassification is an independent prognostic factor. Cancer. 1994; 74:606–617.PubMedCrossRefGoogle Scholar
  10. 10.
    Kirchner T, Schalke B, Buchwald J, Ritter M, Marx A, Müller-Hermelink HK. Well differentiated thymic carcinoma: an organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol. 1992:16; 1153–1169.PubMedCrossRefGoogle Scholar
  11. 11.
    Fukai L, Masaoka A, Hashimoto T, Yamakawa Y, Mizuno T, Tanamura O: Cytokeratins in normal thymus and thymic epithelial tumors. Cancer. 1993; 71:99–105.PubMedCrossRefGoogle Scholar
  12. 12.
    Moll R: Molecular diversity of cytokeratins: significance for cell and tumor differentiation. Acta Histochem Suppl. 1991; 41:117–127.PubMedGoogle Scholar
  13. 13.
    Moll R, Schiller DL, Franke WW. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression pattern. J Cell Biol. 1990; 111:567–580.PubMedCrossRefGoogle Scholar
  14. 14.
    Moll R, Löwe A, Laufer J, Franke WW: Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992; 140:427–447.PubMedGoogle Scholar
  15. 15.
    Colic M, Jovanovic S, Mitrovic S, Dujic A: Immunohistochemical identification of six cytokeratin-defined subsets of the rat thymic epithelial cells. Thymus. 1989; 13:175–85.PubMedGoogle Scholar
  16. 16.
    Colic M, Jovanovic S, Vasiljevski M, Dujic A: Ontogeny of thymic epithelium defined by monoclonal anticytokeratin antibodies. Dev Comp Immunol. 1990; 1:67–75.CrossRefGoogle Scholar
  17. 17.
    Shezen E, Okon E, Ben Hur H, Abramsky O: Cytokeratin expression in human thymus: Immunohistochemical mapping. Cell Tissue Res. 1995; 279:221–231.PubMedCrossRefGoogle Scholar
  18. 18.
    Kuratani S, Bockman DE: Impaired development of the thymic primordium after neural crest ablation. Anat Rec. 1990; 228:185–190.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • J. P. Enoksson
    • 1
  • M. Albertsson
    • 2
  • A. Cervin
    • 2
  • K. Friström
    • 2
  • L. Johansson
    • 1
  1. 1.Department of PathologyLund University HospitalSweden
  2. 2.Department of OncologyLund University HospitalSweden

Personalised recommendations